RhumbLine Advisers’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-872
| Closed | -$8.99K | – | 4310 |
|
|
2023
Q3 | $8.99K | Hold |
872
| – | – | ﹤0.01% | 3885 |
|
|
2023
Q2 | $7.19K | Buy |
+872
| New | +$5.22K | ﹤0.01% | 4008 |
|
|
2022
Q2 | – | Sell |
-23,956
| Closed | -$138K | – | 3290 |
|
|
2022
Q1 | $138K | Sell |
23,956
-32,576
| -58% | -$292K | ﹤0.01% | 2836 |
|
|
2021
Q4 | $848K | Buy |
56,532
+2,070
| +4% | +$37.7K | ﹤0.01% | 2271 |
|
|
2021
Q3 | $1.43M | Sell |
54,462
-7,845
| -13% | -$289K | ﹤0.01% | 2066 |
|
|
2021
Q2 | $3.12M | Sell |
62,307
-822
| -1% | -$36.8K | ﹤0.01% | 1704 |
|
|
2021
Q1 | $2.91M | Buy |
63,129
+875
| +1% | +$41.8K | ﹤0.01% | 1728 |
|
|
2020
Q4 | $2.67M | Buy |
62,254
+3,671
| +6% | +$139K | ﹤0.01% | 1704 |
|
|
2020
Q3 | $2.39M | Sell |
58,583
-3,094
| -5% | -$154K | ﹤0.01% | 1574 |
|
|
2020
Q2 | $3.38M | Sell |
61,677
-1,486
| -2% | -$85K | 0.01% | 1433 |
|
|
2020
Q1 | $3.3M | Buy |
63,163
+686
| +1% | +$37.1K | 0.01% | 1267 |
|
|
2019
Q4 | $3.04M | Buy |
62,477
+4,140
| +7% | +$194K | 0.01% | 1557 |
|
|
2019
Q3 | $3.21M | Buy |
58,337
+3,322
| +6% | +$190K | 0.01% | 1451 |
|
|
2019
Q2 | $2.75M | Buy |
55,015
+4,987
| +10% | +$248K | 0.01% | 1542 |
|
|
2019
Q1 | $2.82M | Buy |
50,028
+1,021
| +2% | +$60.8K | 0.01% | 1510 |
|
|
2018
Q4 | $3.13M | Buy |
49,007
+9,502
| +24% | +$673K | 0.01% | 1378 |
|
|
2018
Q3 | $3.21M | Buy |
39,505
+3,386
| +9% | +$248K | 0.01% | 1390 |
|
|
2018
Q2 | $2.31M | Buy |
36,119
+9,272
| +35% | +$455K | ﹤0.01% | 1599 |
|
|
2018
Q1 | $1.04M | Buy |
26,847
+19,069
| +245% | +$668K | ﹤0.01% | 1924 |
|
|
2017
Q4 | $218K | Sell |
7,778
-1,665
| -18% | -$48.8K | ﹤0.01% | 2590 |
|
|
2017
Q3 | $253K | Buy |
+9,443
| New | +$180K | ﹤0.01% | 2632 |
|
Other funds holding TRHC
RhumbLine Advisers's TRHC Position: Q4 2023 in Review
RhumbLine Advisers sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 872 shares — an estimated $8.99K sold.
RhumbLine Advisers first reported a position in TRHC in Q3 2017 and held it in 21 quarters. The position peaked at $3.38M in Q2 2020. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- RhumbLine Advisers reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- RhumbLine Advisers sold 872 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $8.99K.
- RhumbLine Advisers first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2017 and held it in 21 quarters.
- RhumbLine Advisers's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $3.38M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.